Publications

Quantifying patient- and hospital-level antimicrobial resistance dynamics in Staphylococcus aureus from routinely collected data.

Leclerc, Q; CLEMENTS, A; Dunn, H; Hatcher, J; Lindsay, JA; Grandjean, L; KNIGHT, GM;

2023

Journal of medical microbiology, (2023).72 7 10.1099/jmm.0.001724.

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.

Portnoy, A; Arcand, J-L; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Bakker, R; Patouillard, E; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;

2023

PLoS medicine, (2023).20 7 10.1371/journal.pmed.1004252.

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.

Levin, A; Burgess, C; Shendale, S; Morgan, W; Cw Hutubessy, R; Measles–rubella Eradication Modelling Group,; JIT, M; Measles-rubella Eradication Modelling Group,;

2023

BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011526.

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01 E and BCG-revaccination.

Clark, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; SCARPONI, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2023

medRxiv (2023). 10.1101/2023.02.24.23286406.

Using agent-based modelling to inform incentive design across three levels of care in the payment for performance (P4P) scheme for childbirth care in Tanzania.

Alibrahim, A; FOSS, A; Mziray, N; Binyaruka, P; Maiba, J; CASSIDY, R; Chalabi, Z; BORGHI, J;

2023

. Abstract accepted for oral presentation (2023).

The 'Holy Grail' for Health Systems Modelling: Hybrid Simulation for Strengthened Evaluation of Complex Interventions.

CASSIDY, R; Alibrahim, A; FOSS, A; Semwanga, AR; Mziray, N; Binyaruka, P; BORGHI, J;

2023

. Abstract accepted for oral presentation (2023).

Characterising information gains and losses when collecting multiple epidemic model outputs.

Sherratt, K; Srivastava, A; Ainslie, K; Singh, D; Cublier, A; Marinescu, MC; Carretero, J; Cascajo Garcia, A; Franco, N; Willem, L; Abrams, S; Faes, C; Beutels, P; Hens, N; Müller, S; Charlton, B; Ewert, R; Paltra, S; Rakow, C; Rehmann, J; Conrad, T; Schütte, C; Nagel, K; ABBOTT, S; Grah, R; ... FUNK, S.

2023

medRxiv (2023). 10.1101/2023.07.05.23292245.

Outbreak risks, cases, and costs of vaccination strategies against wild poliomyelitis in polio-free settings: a modelling study.

AUZENBERGS, M; Abbas, K; Voorman, A; Peak, C; JIT, M; O'Reilly, K;

2023

medRxiv (2023). 10.1101/2023.07.05.23292288.

Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.

KIM, C; Holm, M; Frost, I; Hasso-Agopsowicz, M; ABBAS, K;

2023

BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011341.

Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.

Fleming, JA; Baral, R; Higgins, D; Khan, S; Kochar, S; Li, Y; Ortiz, JR; Cherian, T; Feikin, D; JIT, M; Karron, RA; Limaye, RJ; Marshall, C; Munywoki, PK; Nair, H; Newhouse, LC; Nyawanda, BO; Pecenka, C; Regan, K; Srikantiah, P; Wittenauer, R; Zar, HJ; Sparrow, E;

2023

Vaccine, (2023).41 Sup, 10.1016/j.vaccine.2022.09.081.